Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 5441 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  ACELYRIN INC.

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients

Read more ››
By: GlobeNewswire - 11 Mar 2024

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Napigen Inc.

Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Aprea Therapeutics, Inc.

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Integra LifeSciences

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 11 Mar 2024

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Aprea Therapeutics, Inc.

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Dyadic International, Inc.

CenTrak Unveils the Industry’s First BLE Multi-Mode Platform for RTLS at HIMSS 2024

Read more ››
By: GlobeNewswire - 11 Mar 2024

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Journey Medical Corporation

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 11 Mar 2024

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Chromocell Therapeutics Corporation

TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  TransCode Therapeutics, Inc.

Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Alumis Inc.

Konica Minolta Healthcare to Showcase Exa Platform in the Cloud with AWS HealthImaging at HIMSS 2024 Meeting

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Konica Minolta Healthcare Americas, Inc.

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Dyadic International, Inc.

Signia Expands Integrated Xperience (IX) Platform Portfolio with Addition of Discreet, Design-Forward Styletto IX and Insio IX Hearing Aids that Directly Challenge Hearing Aid Stigma

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Signia Therapeutics | Signia Venture Partners

medac unveils new Global Corporate Brand

Read more ››
By: GlobeNewswire - 11 Mar 2024

Phase 1 onCARlytics solid tumour trial advances to combination arm treatment

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Imugene Limited

MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders

Read more ››
By: GlobeNewswire - 11 Mar 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑